ABVEW Above Food Ingredients Inc. - Fundamental Analysis

BEARISH

ABVEW Stock | Fundamental Analysis & Investment Insights

NASDAQ • N/A • N/A

Current Price Live

$0.57

52W High

$0.64

52W Low

$0.42

Overview AI Snowflake Price Valuation Profitability Growth Health

At a glance

Key valuation, profitability, growth, and risk metrics.

Updated Feb 14, 2026

Market cap

N/A

P/E

N/A

ROE

N/A

Profit margin

-23.4%

Debt/Equity

N/A

Dividend yield

N/A

AI Analysis

Confidence Score

92%

Analysis Accuracy

ABVEW exhibits severe financial distress, as indicated by a Piotroski F-Score of 4/9 (borderline stable but weak), a negative Price/Book ratio of -1.31, and a current ratio of just 0.23—signaling acute liquidity issues. The company is unprofitable with negative margins across all key metrics, including a -23.36% profit margin and a 45% year-over-year revenue decline, reflecting deteriorating business fundamentals. With no analyst coverage, no dividend, and a technical trend score of 0/100, the stock lacks both institutional support and momentum. The absence of a Graham Number and intrinsic value estimate further underscores the lack of a defensible valuation anchor. Overall, the company is in a precarious financial position with high risk of insolvency.

Key Strengths

Insider sentiment at 40/100 suggests minimal selling pressure

Current price near 52-week low ($0.42) may offer a technical floor

Low float could amplify short-term volatility if sentiment shifts

Price slightly below 52-week high ($0.64), indicating potential oversold condition

No reported debt or equity data may imply minimal leverage (though likely due to insolvency)

Key Risks

Piotroski F-Score of 4/9 indicates weak financial health and poor operational efficiency

Negative Price/Book ratio (-1.31) implies market capitalization below net asset value, a red flag for asset stripping or insolvency

Current ratio of 0.23 and quick ratio of 0.07 indicate severe liquidity risk and inability to meet short-term obligations

45% YoY revenue decline signals fundamental business deterioration

No analyst coverage and zero dividend yield suggest lack of investor interest and no income return

Performance Snowflake

Multi-dimensional analysis across 5 key categories

Overall

Weak

Value

Future

Past

Health

Dividend

AI Verdict

High Risk

Key drivers: Negative profitability and revenue contraction, Extreme liquidity constraints, Low Piotroski F-Score, No valuation anchors, Absence of analyst coverage

Confidence

95%

Value

15/100

Ref P/E, PEG, Graham Number

Positives

Price near 52-week low may suggest undervaluation on a technical basis

Watchpoints

Negative Price/Book ratio invalidates traditional value metrics
No Graham Number or intrinsic value estimate available
No P/E, PEG, or EV/EBITDA data to support valuation
Market cap likely below net asset value, indicating distress

Future

10/100

Ref Growth rates

Positives

No indication of immediate bankruptcy (yet)

Watchpoints

45% YoY revenue decline with no signs of reversal
No growth metrics available, suggesting stagnation or collapse
Negative margins persist across all levels
No forward guidance or earnings estimates

Past

20/100

Ref Historical trends

Positives

Price has held above $0.42, suggesting some support

Watchpoints

Consistent 0% change across all timeframes (5Y, 3Y, 1Y, etc.) indicates stagnation
No meaningful price appreciation despite volatility
Historical performance shows no recovery or momentum

Health

18/100

Ref Altman Z-Score, Piotroski F-Score

Positives

No reported debt or equity data may imply minimal leverage (though likely due to insolvency)

Watchpoints

Piotroski F-Score of 4/9 indicates weak financial health
Current ratio of 0.23 and quick ratio of 0.07 signal severe liquidity risk
No Altman Z-Score available, but negative margins and declining revenue suggest distress risk
Negative operating and profit margins indicate poor operational efficiency

Dividend

0/100

Ref Yield, Payout

Positives

No standout positives identified.

Watchpoints

No dividend yield or payout ratio
Dividend strength score of 0/100 indicates no income return
No history of dividend payments

Stock Price & Analyst Targets

Real-time price movements and analyst price targets

Current Price

$0.57

Multi-Horizon Performance vs Peers

Price momentum across 5Y → 1W horizons for ABVEW and closest competitors.

Updated 2026-02-13

Company	5Y	3Y	1Y	6M	1M	1W
ABVEW Above Food Ingredients Inc. Primary	0.0%	0.0%	0.0%	0.0%	0.0%	0.0%

Positive values indicate cumulative gains over the specified period. Comparables pulled from the same sector to highlight whether momentum is stock-specific or industry-wide.

Historical Performance Trends

Long-term financial metrics and growth patterns

Revenue & Net Income

Profit & Operating Margins

Return on Equity (ROE)

Quarterly Revenue Growth

Historical data shows last 12 quarters (3 years)

Valuation Metrics

Key valuation ratios and pricing indicators

N/A

-1.31

N/A

Profitability

Profit margins and return metrics

Profit Margin -23.36%

Operating Margin -23.25%

Gross Margin -2.76%

ROE N/A

ROA N/A

Growth

Revenue and earnings growth rates

Revenue Growth -45.0%

Earnings Growth N/A

Q/Q Revenue Growth N/A

Q/Q Earnings Growth N/A

Financial Health

Balance sheet strength and liquidity metrics

Debt/Equity

N/A

Current Ratio

0.23

Weak

Quick Ratio

0.07

Poor

Cash/Share

$0.02

Past News Coverage

Recent headlines mentioning ABVEW from our newsroom.

Newest → oldest

Back to All Stocks

TradingGPT V1 Copilot

Fundamentals • Valuation • Risk

Hi! I'm your fundamentals copilot.

Ask me to:
• Summarize the business quality
• Review valuation and multiples
• Highlight risks and red flags
• Explain growth and margin trends